Computational Toxicology – Risk Assessment for Chemicals
Seiten
2018
Wiley-Blackwell (Hersteller)
978-1-119-28259-4 (ISBN)
Wiley-Blackwell (Hersteller)
978-1-119-28259-4 (ISBN)
- Keine Verlagsinformationen verfügbar
- Artikel merken
A key resource for toxicologists across a broad spectrum of fields, this book offers a comprehensive analysis of molecular modelling approaches and strategies applied to risk assessment for pharmaceutical and environmental chemicals.
Provides a perspective of what is currently achievable with computational toxicology and a view to future developments
Helps readers overcome questions of data sources, curation, treatment, and how to model / interpret critical endpoints that support 21st century hazard assessment
Assembles cutting-edge concepts and leading authors into a unique and powerful single-source reference
Includes in-depth looks at QSAR models, physicochemical drug properties, structure-based drug targeting, chemical mixture assessments, and environmental modeling
Features coverage about consumer product safety assessment and chemical defense along with chapters on open source toxicology and big data
Provides a perspective of what is currently achievable with computational toxicology and a view to future developments
Helps readers overcome questions of data sources, curation, treatment, and how to model / interpret critical endpoints that support 21st century hazard assessment
Assembles cutting-edge concepts and leading authors into a unique and powerful single-source reference
Includes in-depth looks at QSAR models, physicochemical drug properties, structure-based drug targeting, chemical mixture assessments, and environmental modeling
Features coverage about consumer product safety assessment and chemical defense along with chapters on open source toxicology and big data
Sean Ekins, MSc, PhD, DSc has over 20 years of pharmaceutical and toxicology experience. He is the founder or co-founder of two companies and Adjunct Professor at three universities. He has been awarded 16 NIH grants as Principal Investigator. He has authored or co authored over 285 peer-reviewed papers and book chapters and edited five books with Wiley. His research is focused on collaborations to facilitate rare and neglected disease drug discovery.
| Erscheint lt. Verlag | 19.1.2018 |
|---|---|
| Verlagsort | Hoboken |
| Sprache | englisch |
| Maße | 150 x 250 mm |
| Gewicht | 666 g |
| Themenwelt | Naturwissenschaften ► Biologie |
| ISBN-10 | 1-119-28259-4 / 1119282594 |
| ISBN-13 | 978-1-119-28259-4 / 9781119282594 |
| Zustand | Neuware |
| Informationen gemäß Produktsicherheitsverordnung (GPSR) | |
| Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
Online Resource (2024)
Pearson Education Limited (Hersteller)
CHF 53,55
Online Resource (2024)
Pearson Education Limited (Hersteller)
CHF 84,50
